Education
About Us
Working with TipRanks
Follow Us
Jeff L Vacirca Insider Profile
4 Followers
Jeff L Vacirca, Director at Odonate, holds 18.62K shares in Caris Life Sciences, Inc. (Ticker: CAI), holds 151.16K shares in Assertio Therapeutics (Ticker: ASRT), holds 0.00 shares in Spectrum Pharmaceuticals (Ticker: SPPI).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+1.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeff L Vacirca holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeff L Vacirca
Jeff L Vacirca's Trading History
Odonate
Jun 28, 2019
Director
Informative Buy
500.01K
$3.48B
Spectrum Pharmaceuticals
Aug 01, 2023
―
Uninformative Sell
―
$0.00
Assertio Therapeutics
Jun 12, 2024
Director
Informative Buy
11.10K
$1.82M
Caris Life Sciences, Inc.
Feb 27, 2026
Director
Uninformative Buy
49.99K
$369.81K
List of latest transactions for each holding click on a transaction to see Jeff L Vacirca's performance on stock
You May Also Like
Jeff L Vacirca insider profile FAQ
What is the percentage of profitable transactions made by Jeff L Vacirca?
The percentage of profitable transactions made by Jeff L Vacirca is 50%.
What is the average return per transaction made by Jeff L Vacirca?
The average return per transaction made by Jeff L Vacirca is 1.50%.
What stocks does Jeff L Vacirca hold?
Jeff L Vacirca holds: ODTC, SPPI, ASRT, CAI stocks.
What was Jeff L Vacirca’s latest transaction?
Jeff L Vacirca latest transaction was an Uninformative Buy of $49.99K.
What was Jeff L Vacirca's most profitable transaction?
Jeff L Vacirca’s most profitable transaction was an Informative Buy of ODTC stock on March 7, 2019. The return on the trade was 72.20%.
What is Jeff L Vacirca's role in Odonate?
Jeff L Vacirca's role in Odonate is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.